Final answer:
Incretin mimetic antidiabetic drugs are not used to treat type 1 diabetes mellitus. They are primarily used in the treatment of type 2 diabetes mellitus.
Step-by-step explanation:
Incretin mimetic antidiabetic drugs are a class of medications that mimic the action of incretin hormones in the body.
These drugs are primarily used in the treatment of type 2 diabetes mellitus, not type 1 diabetes mellitus. They help to lower blood sugar levels by stimulating insulin release, inhibiting glucagon secretion, slowing down gastric emptying, and increasing feelings of satiety.
Examples of incretin mimetic antidiabetic drugs include exenatide and liraglutide. These drugs are usually administered via subcutaneous injections, not orally.
Learn more about incretin mimetic antidiabetic drugs